Company description

Established in 1832, net sales of US $7 billion, Japan-based trading house having manufacturing companies of finished dosage form (FDF) and excipient. [Nagase Medicals Co., Ltd] A sterile FDF manufacturer, dedicated to production of injectables & liposomal dosage and specialized in oncology filed. [Hayashibara Co., Ltd] The world largest commercial manufacturer of saccharide-base excipients (Trehalose, Maltose and Pullulan).

Quick facts

Sales markets Western Europe; Eastern Europe; Middle East; Asia; North America; Central/South America
Primary business activity Contract Manufacturer; Distributor; Manufacturer; Trading Company
Affiliated categories: Drug Delivery Systems |Drug Formulation (general category) |Lyophilisation More

Upcoming events

30 sep 2020

CPhI Japan 2020

30 September - 2 October 2020 Osaka, Japan Visit us at stand 1H-40 Book a meeting See our Exhibitor Profile   See full Exhibitor List
Nagase & Co., Ltd

Contact information




View all contact information